uthor: M. Bailey Hirschburg

Board members shared updates and heard a rulemaking briefing focused on legislative implementation.

Stakeholders engaged with the agency over development of a study on home delivery of medical cannabis and heard about other patient concerns.

Agency leadership reviewed arguments for processors acting as distributors, learned about the most recent security issue with the state's traceability system, and heard about new dialogue between the Enforcement division and medical cannabis patient advocates.

New Enforcement officers were sworn in before public comments requesting cannabis curbside service and challenges for licensees.

An executive session on hidden ownership investigations was scheduled, the Board expressed skepticism about cannabis-related traffic fatality data, and reacted to an op-ed on cannabis trafficking penned by a federal official.

The Board heard positive feedback on changes to cannabis sampling guidelines before discussing volume discounts and cannabis economic forecasting.

An Independent Verification and Validation (IV&V) Project by Gartner Consulting was presented to the Committee and an executive from MJ Freeway defended the company's software development process.